scispace - formally typeset
L

Luca Diamanti

Researcher at University of Pavia

Publications -  43
Citations -  956

Luca Diamanti is an academic researcher from University of Pavia. The author has contributed to research in topics: Amyotrophic lateral sclerosis & SOD1. The author has an hindex of 14, co-authored 43 publications receiving 596 citations.

Papers
More filters
Journal ArticleDOI

SOD1 in Amyotrophic Lateral Sclerosis: “Ambivalent” Behavior Connected to the Disease

TL;DR: The “ambivalent” behavior of SOD1 in ALS disease will be resolved and sporadic ALS patients will be classified according to a novel biological signature, i.e., SOD localization.
Journal ArticleDOI

Amyotrophic lateral sclerosis and environmental factors.

TL;DR: The role of environmental factors in ALS is analyzed: heavy metals, electromagnetic fields and electric shocks, pesticides, β-N-methylamino-L-alanine, physical activity and the controversial role of sports.
Journal ArticleDOI

Pathological Proteins Are Transported by Extracellular Vesicles of Sporadic Amyotrophic Lateral Sclerosis Patients.

TL;DR: MVs and EXOs size were increased in ALS patients compared to controls and MVs of ALS patients were enriched with toxic proteins compared to CTRLs, which may suggest that MVs can transport toxic proteins and might play a role in prion-like propagation of ALS disease.
Journal ArticleDOI

Long non-coding and coding RNAs characterization in Peripheral Blood Mononuclear Cells and Spinal Cord from Amyotrophic Lateral Sclerosis patients.

TL;DR: A whole transcriptome RNA-seq analysis was performed to investigate the regulation of non-coding and coding RNAs in Sporadic ALS patients, mutated ALS patients and matched controls in Peripheral Blood Mononuclear Cells, offering starting points for new investigations about pathogenic mechanism involved in ALS disease.
Journal ArticleDOI

Combined central and peripheral demyelination: Clinical features, diagnostic findings, and treatment.

TL;DR: The data suggest that CCPD has heterogeneous features and shows frequent post-infectious onset, primary peripheral nervous system or central nervous system involvement, a monophasic or chronic disease course, inadequate response to treatments, and a generally poor outcome.